New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 24, 2012
10:25 EDTVPHM, STR, CTB, TWX, PVH, BODY, RHI, RBCN, LAMR, AGNOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allergan (AGN) upgraded to Outperform from Underperform at CLSA... Body Central (BODY) upgraded to Outperform from Perform at Oppenheimer... Cooper Tire (CTB) upgraded to Buy from Hold at Deutsche Bank... Lamar Advertising (LAMR) upgraded to Outperform from Market Perform at Wells Fargo... PVH Corp. (PVH) upgraded to Overweight from Neutral at Piper Jaffray... Questar (STR) upgraded to Buy from Neutral at UBS... Rubicon (RBCN) upgraded to Neutral from Sell at Goldman... Time Warner (TWX) upgraded to Overweight from Equal Weight at Morgan Stanley... ViroPharma (VPHM) upgraded to Outperform from Market Perform at Wells Fargo... Robert Half (RHI) upgraded to Buy from Neutral at BofA/Merrill.
News For AGN;BODY;CTB;LAMR;PVH;STR;RBCN;TWX;VPHM;RHI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 7, 2015
15:57 EDTTWXHBO says Game of Thrones set to top 20M viewers this season, Bloomberg reports
Subscribe for More Information
10:05 EDTLAMRLamar Advertising acquires Alliance Airport Advertising
Subscribe for More Information
09:26 EDTAGNAllergan deal wise, says BMO Capital
Subscribe for More Information
08:36 EDTAGNPiper Jaffray conference call is cancelled
Biopharmaceuticals Analyst Schimmer, along with Dr. Diana Do, a leading clinician-scientist who specializes in the treatment of retinal conditions at the University of Nebraska, discuss the current practice dynamics and treatment of wet-AMD (age-related macular degeneration), the recent AAVL Phase 2a dataset and key points of debate and emerging treatment options in wet-AMD on an Analyst/Industry conference call to be held on July 7 at 4:30 pm.
07:08 EDTAGNAllergan to acquire rights to Merck's CGRP for $250M
Subscribe for More Information
07:01 EDTTWXAllen & Company to hold a conference
Subscribe for More Information
July 6, 2015
07:10 EDTAGNHorizon Pharma files patent infringement lawsuits against five companies
Subscribe for More Information
07:04 EDTAGNAllergan to acquire Oculeve dry eye disease development programs
Allergan and Oculeve announced that they have entered into an agreement under which Allergan will acquire Oculeve in an all-cash transaction. Under the terms of the agreement, Allergan will acquire Oculeve for a $125M upfront payment and commercialization milestone payments related to Oculeve's lead development program OD-01. The agreement also includes the acquisition of an additional earlier-stage dry eye device development program. Allergan's 2015 earnings-per-share forecast provided on May 11, 2015 is unchanged as a result of the acquisition. The company remains committed to de-levering to below 3.5x debt to Adjusted EBITDA by the end of the first quarter of 2016. The acquisition of Oculeve adds novel, complementary dry eye development programs to Allergan's current eye care research and development programs, including OD-01, a non-invasive nasal neurostimulation device that increases tear production in patients with dry eye disease. Oculeve has completed four clinical studies of OD-01 to date in more than 200 patients, showing positive safety and efficacy of the device. Allergan plans to conduct two additional pivotal trials prior to FDA submission, which is expected in 2016 with potential commercial launch in 2017. The transaction is subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Pending approvals, Allergan anticipates closing the transaction in the third quarter of 2015.
July 5, 2015
16:52 EDTTWXUniversal's 'Jurassic World' leads U.S. weekend box office with $30.9M
Subscribe for More Information
June 29, 2015
17:22 EDTAGNAllergan reports 6.7% stake in KYTHERA
June 28, 2015
15:40 EDTTWXUniversal's 'Jurassic World' leads U.S. weekend box office with $54.2M
For the weekend of June 28, Comcast (CMCSA, CMCSK) subsidiary Universal's "Jurassic World" topped domestic box office charts at $54.2M. Disney's (DIS) "Inside Out" landed in second place with $52.1M, while Universal's "Ted 2" came in third with $32.9M. Time Warner (TWX) subsidiary Warner Bros.' "Max" and Fox's (FOX, FOXA) "Spy" took fourth and fifth place at $12.2M and $7.8M, respectively. Data gathered by Rentrak.
June 26, 2015
10:00 EDTCTBOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:02 EDTCTBCooper Tire reinstated with a Hold at Deutsche Bank
Subscribe for More Information
June 25, 2015
08:13 EDTAGNAllergan CEO: Irvine campus ‘crucial’ to company, L.A. Times reports
New Allergan CEO Brent Saunders said that the company’s Irvine, California campus is “crucial” to the recently purchased organization, the L.A. Times reports, citing comments from Saunders in an interview. Allergan was purchased in March by Actavis, a move which led to the layoff of roughly 600 employees from the Irvine offices, the report says. Saunders said that the “bleeding has stopped” after a round of layoffs, the L.A. Times says. Reference Link
07:27 EDTPVHPVH Corp. remains top softlines pick, says UBS
UBS said PVH Corp. remains its top softlines pick, citing improving Q2 trends, confidence that the company will report a beat and raise quarter and multiple sources of earnings upside and multiple expansion that will drive stock performance. UBS reiterated its Buy rating and $132 price target on PVH Corp.
June 24, 2015
14:46 EDTTWXHBO deal an early sign of Facebook original content plans, says Brean Capital
Subscribe for More Information
12:27 EDTTWXHBO to offer free episodes of 'Ballers', 'The Brink' on Facebook, Variety says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use